Across TCGA pan-cancer cohorts, TRAJ47 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated TRAJ47 data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher TRAJ47 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRAJ47 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LUSC show a favorable association.
LIHC, KIRP, and MESO are the cancer types where TRAJ47 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.